79
Participants
Start Date
October 29, 2018
Primary Completion Date
May 3, 2023
Study Completion Date
May 3, 2023
Spesolimab
Solution
AKH - Medical University of Vienna, Vienna
UZ Leuven, Leuven
Centre Hospitalier Universitaire de Liège, Liège
Ordensklinikum Linz GmbH - Barmherzige Schwestern, Linz
Columbia University Medical Center-New York Presbyterian Hospital, New York
Istituto Clinico Humanitas, Rozzano (MI)
Asklepios Kliniken Westklinikum Hamburg, Hamburg
Hunter Holmes McGuire VA Medical Center, Richmond
Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel
Emory University, Atlanta
Medizinische Hochschule Hannover, Hanover
Azienda Ospedaliera Universitaria di Padova, Padua
Hospital Virgen del Rocío, Seville
Yeungnam University Medical Center, Daegu
Hospital Politècnic La Fe, Valencia
Inje University Haeundae Paik Hospital, Busan
University of Chicago, Chicago
Digestive Disease Specialists Inc, Oklahoma City
Klinikum Esslingen GmbH, Esslingen am Neckar
Texas Digestive Disease Consultants - Southlake, Southlake
Southern Star Research Institute, LLC, San Antonio
Universitätsklinikum Ulm, Ulm
Universitätsklinikum Erlangen, Erlangen
"Federal State Budgetary Institution State Scientific Center of Coloproctology MOH Russia", Moscow
Military Medical Academy n.a. C. M. Kirov, St. Petersburg, Saint Petersburg
FSB Instit. HC Irkutsk Scient.Cent. Sibirian Branch of Russ. Acad. Scien., Irkutsk
Medical Research Center of Connecticut, LLC, Hamden
Victoria Hospital (LHSC), London
Sapporo Tokushukai Hospital, Hokkaido, Sapporo
Sapporo Higashi Tokushukai Hospital, Hokkaido, Sapporo
Hyogo College of Medicine Hospital, Hyogo, Nishinomiya
Ofuna Chuo Hospital, Kanagawa, Kamakura
Tokyo Medical and Dental University Hospital, Tokyo, Bunkyo-ku
Tokyo Yamate Medical Center, Tokyo, Shinjuku
National Medical Institute MSWiA, Warsaw
Doncaster Royal Infirmary, Doncaster
Guy's Hospital, London
Whiston Hospital, Prescot
Lead Sponsor
Boehringer Ingelheim
INDUSTRY